Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within Interleukin-6 family cytokines
Anne Huber(La Trobe University), Moritz F. Eissmann(La Trobe University)
Cited by 1
Related Papers
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
|Nature Communications|2019|228